Role of time from transplantation to biopsy in histologic ABMR: A single center report

Jorge Chancay, Caroline Liu, Kinsuk Chauhan, Lisa Andersen, Cynthia Harris, Steven Coca, Veronica Delaney, Fasika Tedla, Graciela De Boccardo, Vinita Sehgal, Dennis Moledina, Richard Formica, Anand Reghuvaran, Khadija Banu, Sander Florman, Enver Akalin, Ron Shapiro, Fadi Salem, Madhav C. Menon

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Background: Allograft biopsies with lesions of Antibody-Mediated Rejection (ABMR) with Microvascular Inflammation (MVI) have shown heterogeneous etiologies and outcomes. Methods: To examine factors associated with outcomes in biopsies that meet histologic ABMR criteria, we retrospectively evaluated for-cause biopsies at our center between 2011 and 2017. We included biopsies that met the diagnosis of ABMR by histology, along with simultaneous evaluation for anti-Human Leukocyte Antigen (HLA) donor-specific antibodies (DSA). We evaluated death-censored graft loss (DCGL) and used a principal component analysis (PCA) approach to identify key predictors of outcomes. Results: Out of the histologic ABMR cohort (n = 118), 70 were DSA-positive ABMR, while 48 had no DSA. DSA(+)ABMR were younger and more often female recipients. DSA(+)ABMR occurred significantly later post-transplant than DSA(-)ABMR suggesting time-dependence. DSA(+)ABMR had higher inflammatory scores (i,t), chronicity scores (ci, ct) and tended to have higher MVI scores. Immunodominance of DQ-DSA in DSA(+)ABMR was associated with higher i+t scores. Clinical/histologic factors significantly associated with DCGL after biopsy were inputted into the PCA. Principal component-1 (PC-1), which contributed 34.8% of the variance, significantly correlated with time from transplantation to biopsy, ci/ct scores and DCGL. In the PCA analyses, i, t scores, DQ-DSA, and creatinine at biopsy retained significant correlations with GL-associated PCs. Conclusions: Time from transplantation to biopsy plays a major role in the prognosis of biopsies with histologic ABMR and MVI, likely due to ongoing chronic allograft injury over time.

Original languageEnglish (US)
Article numbere14802
JournalClinical Transplantation
Issue number12
StatePublished - Dec 2022


  • biopsy
  • classification systems: Banff classification
  • rejection: antibody-mediated (ABMR)

ASJC Scopus subject areas

  • Transplantation


Dive into the research topics of 'Role of time from transplantation to biopsy in histologic ABMR: A single center report'. Together they form a unique fingerprint.

Cite this